Crohn's Disease and Infliximab
Links shared publicly online about this topic
The Optimisation of Infliximab Therapy in Crohn’s Disease | Gastroenterology
touchgastroenterology.com — “Crohn’s disease, therapy, optimisation, infliximab, dosing, switching” View full resource at touchgastroenterology.com
Most Recently Shared on May 27, 2011 at 11:51 am By:
touchGASTRO Gastroenterology and Medical Journal
The Optimisation of Infliximab Therapy in Crohn’s Disease http://bit.ly/lQtD7J
Infliximab Successfully Treats Cystic Fibrosis And Crohn's Disease
medicalnewstoday.com — “Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive. CF involves an anomalou” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2010 at 5:12 pm By:
Infliximab Successfully Treats Cystic Fibrosis And Crohn's Disease http://mnt.to/3Bv5 #crohns #ibd
NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease
medicalnewstoday.com — “In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active Crohn's disease whose condition has not respond” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2010 at 4:37 am By:
NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease In final draft guidance.. http://bit.ly/cAsG7S
Cystic fibrosis and Crohn's disease treated successfully with infliximab
physorg.com — “A research team from Italy reported a case of a 23-year-old patient suffering from cystic fibrosis (CF) and Crohn's disease who was successfully treated with infliximab. This case report was thought to be one of the first regarding the use of biological therapy in patients with CF.” View full resource at physorg.com
Most Recently Shared on April 19, 2010 at 2:43 pm By:
PhysOrg Health News Health News
Cystic fibrosis and Crohn's disease treated successfully with infliximab http://tw.physorg.com/190892601
Infliximab may help prevent post-operative Crohn's disease recurrence
eurekalert.org — “The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease. To date, there have been no randomized controlled trials evaluating infliximab for postoperative Crohn's disease prevention.” View full resource at eurekalert.org
Most Recently Shared on February 1, 2009 at 5:42 am By:
AAAS Infliximab may help prevent post-operative Crohn's disease recurrence http://tinyurl.com/bs8bax
Does Infliximab Worsen Strictures in Crohn's Disease? - QualityPoint Technologies
qualitypointtech.net — “A Medscape reader wonders if giving anti-TNF agents to patients with Crohn's disease could actually be making strictures worse. Medscape Gastroenterology” View full resource at qualitypointtech.net
Most Recently Shared on October 8, 2010 at 11:12 am By:
Does Infliximab Worsen Strictures in Crohn's Disease?: A Medscape reader wonders if giving anti-TNF agents to pat... http://bit.ly/d1EDy2
Lives Changed by REMICADE (infliximab)
remicade.com — “Read stories from actual REMICADE" (infliximab) patients who have gone through Crohn's disease treatment.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:34 am By:
Susan Scroggins Active Health Library and Health Advocate
Crohn's disease patients who have experience relief through the use of Remicade share their personal stories. http://bit.ly/9Rb8FE
REMICADE (infliximab) and Crohn's - Accent 1 Study
remicade.com — “Accent 1, the largest clinical trial ever conducted for Crohn's treatment, was designed to compare the effectiveness of REMICADE" (infliximab) over a 54-week period versus a single dose.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:30 am By:
Susan Scroggins Active Health Library and Health Advocate
The ACCENT I study showed that Remicade may offer Crohn's disease patients remission in as little as two weeks. http://bit.ly/9jqTHM
REMICADE (infliximab) and Crohn's - Accent 2 Study
remicade.com — “Accent 2, the largest clinical trial ever conducted for Crohn's treatment, was designed to compare the effectiveness of REMICADE" (infliximab) over a 54-week period versus a single dose.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:16 am By:
Susan Scroggins Active Health Library and Health Advocate
Approval for Remicade maintenance therapy in fistulizing Crohn’s disease was based on results of the ACCENT II study. http://bit.ly/c5C05g
Gastroenterology Article | Crohn's disease
mdlinx.com — “Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis” View full resource at mdlinx.com
Most Recently Shared on June 30, 2011 at 7:39 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analy... http://bit.ly/jdN369 #GI
Crohn’s Disease Study on Infliximab, Azathioprine « Mayo Clinic News
newsblog.mayoclinic.org — “Crohn’s Disease Study on Infliximab, Azathioprine « Mayo Clinic News” View full resource at newsblog.mayoclinic.org
Most Recently Shared on October 6, 2008 at 5:31 pm By:
Mayo Clinic News Crohn’s Disease Study on Infliximab, Azathioprine: A study led by May.. http://tinyurl.com/3rm9az
NICE recommends infliximab and adalimumab for Crohn's disease treatment | News | Nursing Times
nursingtimes.net — “In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active Crohn's disease whose condition has not responded to conventional therapy, or who are intolerant of or have contraindications to conventional therapy.” View full resource at nursingtimes.net
Most Recently Shared on March 4, 2010 at 11:55 am By:
News: NICE recommends infliximab and adalimumab for Crohn's disease treatment http://bit.ly/dvpjj3
Gastroenterology Article | Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective randomised SWITCH trial
mdlinx.com — “Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective randomised SWITCH trial” View full resource at mdlinx.com
Most Recently Shared on October 10, 2011 at 11:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective rando... http://t.co/AZ3F6oEe #GI
Is Infliximab Appropriate for Stricturing-Type Crohn's Disease? - QualityPoint Technologies
qualitypointtech.net — “Our expert explains why anti-TNF agents might, or might not, be effective in some patients with Crohn's disease. Medscape Gastroenterology” View full resource at qualitypointtech.net
Most Recently Shared on August 13, 2010 at 5:51 pm By:
Is Infliximab Appropriate for Stricturing-Type Crohn's Disease?: Our expert explains why anti-TNF agents might, o... http://bit.ly/dov8Cq
REMICADE (infliximab) and CD Clinical Studies
remicade.com — “Both REMICADE" (infliximab) and Crohn's disease have been subject to clinical studies. Learn the results.” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:32 am By:
Susan Scroggins Active Health Library and Health Advocate
Remicade has been evaluated for the treatment of Crohn's disease in clinical studies. Learn how Remicade fared. http://bit.ly/cJyoua
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
touchGASTRO
Touch GASTROENTEROLOGY is a medical journal informing professions about the latest advances. Including fighting Ulcerative colitis & fields such as Rheumatology
-
MNT Crohn's / IBD
The latest crohn's disease and IBD news published daily. Articles from research centers, universities and prestigious journals.
-
medical_tweets
Advertisement
